Abstract:Disturbance or insufficiency of the tear film challenges the regulatory systems of the ocular surfaces. The reaction of the surfaces includes temporary mechanisms engaged in the preservation of homeostasis. However, strong or persisting challenges can lead to the potential exhaustion of the coping capacity. This again activates the vicious circle with chronic inflammation and autocatalytic deterioration. Hence, the factors challenging the homeostasis should be addressed in time. Amongst them are a varying osmolarity, constant presence of small lesions at the epithelium, acidification, attrition with mechanical irritation, and onset of pain and discomfort. Each of them and, especially when occurring simultaneously, impose stress on the coping mechanisms and lead to a stress response. Many stressors can culminate, leading to an exhaustion of the coping capacity, outrunning normal resilience. Reaching the limits of stress tolerance leads to the manifestation of a lubrication deficiency as the disease we refer to as dry eye disease (DED). To postpone its manifestation, the avoidance or amelioration of stress factors is one key option. In DED, this is the target of lubrication therapy, substituting the missing tear film or its components. The latter options include the management of secondary sequelae such as the inflammation and activation of reparative cascades. Preventive measures include the enhancement in resilience, recovery velocity, and recovery potential. The capacity to handle the external load factors is the key issue. The aim is to guard homeostasis and to prevent intercellular stress responses from being launched, triggering and invigorating the vicious circle. Considering the dilemma of the surface to have to cope with increased time of exposure to stress, with simultaneously decreasing time for cellular recovery, it illustrates the importance of the vicious circle as a hub for ocular surface stress. The resulting imbalance triggers a continuous deterioration of the ocular surface condition. After an initial phase of the reaction and adaption of the ocular surface to the surrounding challenges, the normal coping capacity will be exhausted. This is the time when the integrated stress response (ISR), a protector for cellular survival, will inevitably be activated, and cellular changes such as altered translation and ribosome pausing are initiated. Once activated, this will slow down any recovery, in a phase where apoptosis is imminent. Premature senescence of cells may also occur. The process of prematurization due to permanent stress exposures contributes to the risk for constant deterioration. The illustrated flow of events in the development of DED outlines that the ability to cope, and to recover, has limited resources in the cells at the ocular surface. The reduction in and amelioration of stress hence should be one of the key targets of therapy and begin early. Here, lubrication optimization as well as causal treatment such as the correction of anatomical anomalies (leading to anatomical dry eye) should be a prime intent of any therapy. The features of cellular stress as a key hub for the vicious circle will be outlined and discussed.

The Subtle Role of Para-inflammation in Modulating the Progression of Dry Eye Disease

The Alterations of Ocular Surface Metabolism and the Related Immunity Inflammation in Dry Eye

The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options

NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease

New Perspectives in the Pathophysiology and Treatment of Pain in Patients with Dry Eye Disease

Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review

Ion Channels as Potential Drug Targets in Dry Eye Disease and Their Clinical Relevance: A Review

Role of Inhibiting Inflammation of LC3-Associated Phagocytosis in Dry Eye Disease

One Soul and Several Faces of Evaporative Dry Eye Disease

An Updated Review of Current Insights and Future Perspectives

Cellular Stress in Dry Eye Disease—Key Hub of the Vicious Circle

Genistein‐Calcitriol Mitigates Hyperosmotic Stress‐Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease

Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine

Lymphocytes in Dry Eye Disease

Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface

Management Strategies for Evaporative Dry Eye Disease and Future Perspective

Current Advances in Regenerative Strategies for Dry Eye Diseases: A Comprehensive Review

Dry eye syndrome: developments and lifitegrast in perspective

Single-cell landscape reveals the epithelial cell-centric pro-inflammatory immune microenvironment in dry eye development

Dry Eye Disease and Tear Cytokine Levels—A Meta-Analysis

The role of exocytotic proteins in the (dys)regulation of human reflex tearing and aqueous‐deficient dry eye syndrome